The US dried bloodspot collection card market is growing due to increasing adoption of convenient sample collection methods in diagnostics, newborn screening, and clinical research. The strong presence of advanced healthcare infrastructure, research organizations, and diagnostic companies is supporting market growth. Rising demand for minimally invasive testing solutions is further driving adoption across healthcare applications.
The Dried Bloodspot Collection Card Market size is expected to reach US$ 617.57 Million by 2034 from US$ 424.66 Million in 2025. The market is estimated to record a CAGR of 4.79% from 2026 to 2034.
Growth Factors Driving the Dried Bloodspot Collection Card Market
The increasing need for simple and cost-effective blood sample collection solutions is a major factor supporting market expansion. Dried bloodspot collection cards offer advantages such as easy handling, reduced storage requirements, and convenient transportation, making them valuable for diagnostic and research purposes.
Get Sample PDF - https://www.theinsightpartners.com/sample/TIPRE00040878
The growing focus on early disease detection and expanding applications in clinical studies are also driving demand for dried bloodspot collection solutions. Healthcare organizations and research institutions are adopting these methods to improve sample management and enhance testing efficiency.
Technological Advancements in Blood Sample Collection
Advancements in diagnostic technologies and laboratory testing methods are improving the applications of dried bloodspot collection cards. Enhanced card designs and improved sample preservation techniques are supporting better accuracy and reliability in laboratory analysis.
The integration of advanced analytical technologies is further increasing the use of dried bloodspot samples in various applications. These developments are helping researchers and healthcare professionals conduct efficient testing while reducing challenges associated with traditional blood collection methods.
Increasing Applications in Diagnostics and Research
Dried bloodspot collection cards are widely used in newborn screening, disease monitoring, pharmaceutical research, and clinical studies. Their ability to simplify sample collection makes them suitable for use in different healthcare and research environments.
The growing demand for decentralized testing and remote sample collection is contributing to market growth. Dried bloodspot methods allow samples to be collected outside traditional laboratory settings, supporting broader access to diagnostic testing and research activities.
Rising Adoption in Pharmaceutical and Clinical Studies
Pharmaceutical and biotechnology companies are increasingly using dried bloodspot collection cards in clinical research and drug development activities. These cards help simplify sample collection and improve the efficiency of biological sample analysis.
The expansion of clinical research activities and increasing focus on advanced testing methods are creating new opportunities for market development. Researchers are adopting dried bloodspot technologies to support biomarker studies and improve sample management processes.
Market Trends and Industry Developments
The dried bloodspot collection card market is witnessing increased focus on improving sample quality, storage efficiency, and testing accuracy. Companies are investing in developing advanced collection solutions to meet the growing needs of healthcare and research sectors.
Strategic collaborations and technological innovations are supporting the development of improved blood sampling solutions. These advancements are expected to increase the adoption of dried bloodspot collection methods across diagnostic and research applications.
Key Players
Leading companies operating in the dried bloodspot collection card market are focusing on product development, advanced sample collection solutions, and expansion of diagnostic applications. Key players include:
- Thermo Fisher Scientific
- PerkinElmer
- F. Hoffmann-La Roche
- Abbott Laboratories
- Bio-Rad Laboratories
- Neogen Corporation
- GFE GmbH
- Enzo Biochem
- Scisco
- Sanguine BioSciences
These companies are contributing to market growth by developing innovative collection technologies, improving sample processing capabilities, and supporting healthcare and research organizations.
Future Outlook
The future of the dried bloodspot collection card market is expected to remain positive due to increasing demand for convenient diagnostic methods and expanding applications in healthcare research. Growing interest in remote testing solutions, personalized medicine, and efficient sample collection approaches is expected to create new growth opportunities.
The adoption of advanced laboratory technologies, improved sample preservation methods, and increasing use in clinical research are likely to support market expansion. As healthcare systems continue focusing on accessible and efficient diagnostic solutions, dried bloodspot collection cards are expected to gain wider adoption through 2034.
Top Trending Reports:
Blood Bank Market Regional Share, Size, Trends, and Forecast by 2031
About Us
The Insight Partners is a leading market research and consulting firm delivering actionable insights through in-depth industry analysis and strategic intelligence. The firm supports clients across various industries in making informed business decisions by providing comprehensive market forecasts, competitive assessments, and growth opportunities.
Contact Us
The Insight Partners
Email: sales@theinsightpartners.com
Phone: +1-646-491-9876
Website: www.theinsightpartners.com